287 related articles for article (PubMed ID: 36286646)
1. [Peculiarities of blood coagulation disorders in patients with COVID-19].
Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
[TBL] [Abstract][Full Text] [Related]
2. Altered platelet and coagulation function in moderate-to-severe COVID-19.
Litvinov RI; Evtugina NG; Peshkova AD; Safiullina SI; Andrianova IA; Khabirova AI; Nagaswami C; Khismatullin RR; Sannikova SS; Weisel JW
Sci Rep; 2021 Aug; 11(1):16290. PubMed ID: 34381066
[TBL] [Abstract][Full Text] [Related]
3. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
4. Coagulopathy of Coronavirus Disease 2019.
Iba T; Levy JH; Levi M; Connors JM; Thachil J
Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-related laboratory coagulation findings.
Devreese KMJ
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
[TBL] [Abstract][Full Text] [Related]
6. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H; Ogawa H
Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
Tang N; Bai H; Chen X; Gong J; Li D; Sun Z
J Thromb Haemost; 2020 May; 18(5):1094-1099. PubMed ID: 32220112
[TBL] [Abstract][Full Text] [Related]
8. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy in COVID-19.
Iba T; Levy JH; Levi M; Thachil J
J Thromb Haemost; 2020 Sep; 18(9):2103-2109. PubMed ID: 32558075
[TBL] [Abstract][Full Text] [Related]
10. Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
An H; Zhang J; Zhou T; Li T; Li S; Huang C; Chen C; Ying B; Xu Z; Jin S; Li X; Li M
Clin Immunol; 2021 Nov; 232():108852. PubMed ID: 34520860
[TBL] [Abstract][Full Text] [Related]
11. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
[TBL] [Abstract][Full Text] [Related]
12. ROLE OF THROMBODYNAMICS GLOBAL COAGULATION TEST IN IMPROVING TREATMENT RESULTS IN PATIENTS WITH CORONAVIRUS INFECTION AT A COVID-19 HOSPITAL.
Krylov A; Khorobrykh T; Petrovskaya A; Khmyrova S; Agadzhanov V; Khusainova N
Georgian Med News; 2021 Apr; (313):72-79. PubMed ID: 34103434
[TBL] [Abstract][Full Text] [Related]
13. The Impact of COVID-19 Disease on Platelets and Coagulation.
Wool GD; Miller JL
Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
[TBL] [Abstract][Full Text] [Related]
14. Major coagulation disorders and parameters in COVID-19 patients.
Teimury A; Khameneh MT; Khaledi EM
Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
Levi M; Iba T
Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
[TBL] [Abstract][Full Text] [Related]
16. Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.
Kazmi S; Herekar F; Sarfaraz S
Semin Thromb Hemost; 2021 Jun; 47(4):427-430. PubMed ID: 33336328
[No Abstract] [Full Text] [Related]
17. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.
Ragnoli B; Da Re B; Galantino A; Kette S; Salotti A; Malerba M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240292
[TBL] [Abstract][Full Text] [Related]
18. Coagulation and anticoagulation in COVID-19.
Hadid T; Kafri Z; Al-Katib A
Blood Rev; 2021 May; 47():100761. PubMed ID: 33067035
[TBL] [Abstract][Full Text] [Related]
19. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
20. COVID-19-induced coagulopathy: Experience, achievements, prospects.
Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
